Fertility patients sold unnecessary add-on treatments, regulator warnson March 26, 2025 at 10:25 am

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Despite little proof add-ons help, many IVF clinics offer them, the UK’s fertility regulator warns.

Fertility patients sold unproven add-ons, HFEA says

1 hour ago

Michelle Roberts

Digital health editor, BBC News
Getty Images A parent touches the hand of their newborn babyGetty Images

Many fertility patients in the UK are being offered unnecessary add-on treatments that have little or no proof of improving the likelihood of pregnancy, a report suggests.

Add-ons are optional, non-essential treatments some private clinics offer in addition to proven treatments, such in-vitro fertilisation (IVF).

According to the regulator, the Human Fertilisation and Embryology Authority (HFEA) , 73% of 1,500 patients surveyed between September and October 2024 said they had used an add-on in their latest round of treatment.

Most said they had done so based on the clinic’s recommendation.

And only about one in every three said the possible risks had been explained to them.

Spending money

HFEA director Clare Ettinghausen told BBC Radio 4’s Today programme: “This is people themselves reporting on whether they took perhaps an additional supplement, like a vitamin tablet, or had a test or perhaps something like acupuncture.

“We have looked at the evidence… they are not necessarily going to increase the chance of having a baby.

“So we are worried that people are spending money unnecessarily.”

Some of the add-ons can cost thousands of pounds.

And while the HFEA has no power to stop or fine clinics, it is reminding them they must give patients a clear idea of what add-ons involve, how likely they are to help and how much they cost.

The regulator also has its own traffic-light rating tool to help patients decide.

Examples include:

  • Genetic tests
  • Endometrial scratching – where a small area of the womb lining is scraped to trigger processes in the hope it will help the embryo implant
  • Assist hatching – where a small crack is created in the embryo’s outer layer

Overall, patients were satisfied with the care they were receiving, Ms Ettinghausen said.

But the HFEA is concerned NHS patients are waiting longer than those going private.

Just over one out of every two private patients started treatment within a year, compared with one out of every three NHS patients.

A Department of Health and Social Care spokesperson said: “It is unacceptable fertility patients are being offered unnecessary treatments that will not help them in their goal of becoming parents.

“We are working to improve access to NHS fertility services for all who need it.

“We are also currently considering advice from the HFEA about priorities for law reform covering their regulatory powers, including their potential role in digital clinics.”

- Advertisement -

Discover

Sponsor

Latest

The Papers: West ‘to arm’ resistance, and cyber-attack warningon February 20, 2022 at 12:06 am

Developments in the rising tensions at the Ukrainian-Russian border feature on Sunday's front pages.

Brentford stabbing: Man killed and woman in her 80s hospitalisedon November 13, 2021 at 9:04 am

A man, believed to be in his 20s, and a woman in her 80s have been attacked in Brentford.Image source, PA MediaA man has...

The Papers: ‘China security risk’ and ‘Couzens police failings’on February 13, 2023 at 11:57 pm

Tuesday's papers focus on apparent spy balloons in the US, as well as the cost of living crisis.Tuesday's papers focus on apparent spy balloons...

Premier League mid-season report: Phil McNulty assesses all 20 teams’ performanceson January 11, 2024 at 6:13 am

BBC Sport's chief football writer Phil McNulty assesses the performance of every Premier League team.BBC Sport's chief football writer Phil McNulty assesses the performance...

Offshore Oil and Gas Sector Dying After Historic 300% Oil Price Crash

The offshore drilling market is set to be one of the worst-hit in the oil price crash and demand collapse, as companies are reassessing...